Skip to ContentSkip to Navigation
About us Latest news News News articles

Infections, inflammation and venous thrombosis. An epidemiological perspective

28 March 2012

PhD ceremony: Mr. Y.I.G.V. Tichelaar, 12.45 uur, Academiegebouw, Broerstraat 5, Groningen

Dissertation: Infections, inflammation and venous thrombosis. An epidemiological perspective

Promotor(s): prof. J.C. Kluin-Nelemans

Faculty: Medical Sciences

Inflammation and coagulation share many pathways. In this thesis we showed that infections, such as (upper) airway, gastro-intestinal and malaise symptoms, increase the risk of venous thrombosis about 2.5-fold. Chronic inflammatory and infectious diseases also increase the risk of venous thrombosis as high as 8-fold when having a flare-up of chronic inflammatory bowel disease. We showed that patients with HIV-infection have an increased risk of venous and arterial thrombosis and that a super infection with cytomegalovirus disturbs the coagulation hemostasis even more, tipping the balance towards a pro-coagulant state. Also, a high glucose level was associated with an increased risk of venous thrombosis, but conclusions about causality cannot be drawn from our studies. This is also true for high factor VIII levels. About 66% of high factor VIII levels at presentation remained high during and after treatment. An association with the acute phase was found which was not identified in previous studies. The highest levels of factor VIII were least affected by the acute phase reaction. It might be that these patients with an increased risk of a recidive venous thrombosis can be identified early (at presentation). Finally, we found that factor VIII:C levels, determined by one stage clotting assays and chromogenic assays, were falsely lowered by Rivaroxaban, a new anti-Xa oral anticoagulant. Physicians should be aware of this interference.

Last modified:13 March 2020 12.59 a.m.
View this page in: Nederlands

More news

  • 29 November 2023

    UMCG opent nieuwe faciliteit voor microbioomonderzoek 

    Vandaag opent het UMCG de Groningen Microbioom Hub: een nieuwe faciliteit met state-of-the-art technologie waarin alle UMCG-expertise op het gebied van microbioomonderzoek samenkomt. Dit zorgt voor unieke mogelijkheden in onderzoek en maakt nieuwe...

  • 28 November 2023

    Science: more exciting than showbiz

    Science often seems very complicated. Most people probably don't really know what researchers do, and what it takes to make a breakthrough. That is why it is important to keep the general public informed of what is happening in science, says Iris...

  • 13 November 2023

    UMCG beantwoordt vragen patiënten met hulp van AI

    Het UMCG zet kunstmatige intelligentie (artificial intelligence, afgekort AI) in om zorgverleners te helpen bij het beantwoorden van schriftelijke vragen van patiënten. Dit gebeurt in samenwerking met andere ziekenhuizen vanuit de EPIC Nederlandse...